mitomycin has been researched along with pd 98059 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davidson, MK; Draper, BK; Komurasaki, T; Nanney, LB | 1 |
Chen, QL; Du, J; Lu, YY; Su, SB; Wang, XF; Zhang, H; Zhou, QM | 1 |
2 other study(ies) available for mitomycin and pd 98059
Article | Year |
---|---|
Epiregulin is more potent than EGF or TGFalpha in promoting in vitro wound closure due to enhanced ERK/MAPK activation.
Topics: Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Epidermal Growth Factor; Epiregulin; Flavonoids; Humans; Immunoblotting; In Vitro Techniques; Keratinocytes; Mitogen-Activated Protein Kinases; Mitomycin; Nucleic Acid Synthesis Inhibitors; Signal Transduction; Transforming Growth Factor alpha; Wound Healing | 2003 |
Synergistic effect of combinatorial treatment with curcumin and mitomycin C on the induction of apoptosis of breast cancer cells: a cDNA microarray analysis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Curcumin; Drug Synergism; Female; Flavonoids; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; MCF-7 Cells; Mice; Mice, Nude; Mitomycin; Oligonucleotide Array Sequence Analysis; Signal Transduction; Transplantation, Heterologous | 2014 |